Improved RhCMV/SIV Vaccine Efficacy via IL-10 Pathway Modulation

Grant

Date/time Interval

  • September 24, 2018 - August 31, 2023

    • Awarded By

    Total Award Amount

  • 132331.00

    • Direct Costs

  • 89112.00

    • Sponsor Award Id

  • A19-1756-S001

    • Contributor

  • Mark Walter Ph.D.   Principal Investigator